OMB Individually Reported

Data & Analytics: Transportation OCR

Medium riskExact public inventory row

Description

DEA needs a reliable, accurate way to identify the cartel or other organization associated with a seized drug exhibit.

Detailed example

The technology can "fingerprint" drug seizures of various forms (e.g. packaging, powder, pills). The output is a series of best matches for experienced DEA personnel to evaluate for possible matches to associated organizations or details from previously collected drug seizures.

AI / analytics pattern

Classical/Predictive Machine Learning: Models trained on data to make predictions or classifications based on identified patterns or relationships.

Automation level / stage

a) Pre-deployment – The use case is in a development or acquisition status.

Expected benefit

AI capabilities can enable DEA to identify cartels or others organizations associated with drug seizures. This could improve DEA's understanding of drug trends.

Audit / financial statement impact

Does not produce an output that serves as a principal basis for decisions or actions with legal, material, binding, or significant effect on any of the individuals or entities identified in OMB-25-21.

Controls / human review

ATO: Not reported; PIA: Not published